Related Experiment Video
Updated: Feb 7, 2026

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth
Published on: September 22, 2021
New Directions in the Study and Treatment of Metastatic Cancer
Byunghee Yoo1, Bryan C Fuchs2, Zdravka Medarova1
1MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Abstract:
Traditional cancer therapy has relied on a strictly cytotoxic approach that views non-metastatic and metastatic tumor cells as identical in terms of molecular biology and sensitivity to therapeutic intervention. Mounting evidence suggests that, in fact, non-metastatic and metastatic tumor cells differ in key characteristics that could explain the capacity of the metastatic cells to not only escape the primary organ but also to survive while in the circulation and to colonize a distant organ. Here, we lay out a framework for a new multi-pronged therapeutic approach. This approach involves modifying the local microenvironment of the primary tumor to inhibit the formation and release of metastatic cells; normalizing the microenvironment of the metastatic organ to limit the capacity of metastatic tumor cells to invade and colonize the organ; remediating the immune response to tumor neoantigens; and targeting metastatic tumor cells on a systemic level by restoring critical and unique aspects of the cell's phenotype, such as anchorage dependence. Given the limited progress against metastatic cancer using traditional therapeutic strategies, the outlined paradigm could provide a more rational alternative to patients with metastatic cancer.
Insights
Metastatic cancer cells differ from non-metastatic ones, requiring new therapeutic strategies. This study proposes a multi-pronged approach targeting the tumor microenvironment and immune response for better metastatic cancer treatment.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Traditional cancer therapies often treat non-metastatic and metastatic tumor cells identically.
- Emerging evidence highlights distinct molecular and biological characteristics between non-metastatic and metastatic tumor cells.
- These differences explain metastatic cells' ability to invade, survive circulation, and colonize distant organs.
Purpose of the Study:
- To propose a novel, multi-pronged therapeutic framework for treating metastatic cancer.
- To address the limitations of conventional cytotoxic approaches in managing metastatic disease.
Main Methods:
- Modifying the primary tumor's microenvironment to prevent metastatic cell formation and release.
- Normalizing the metastatic organ's microenvironment to impede tumor cell invasion and colonization.
- Enhancing the immune response against tumor neoantigens.
- Systemically targeting metastatic cells by restoring unique phenotypic traits, such as anchorage dependence.
Main Results:
- The proposed framework offers a paradigm shift from traditional cytotoxic methods.
- It integrates local, systemic, and immunomodulatory strategies for comprehensive metastatic cancer management.
Conclusions:
- A multi-pronged therapeutic strategy is a more rational alternative for patients with metastatic cancer.
- This novel approach could improve outcomes by targeting the distinct biology of metastatic cells and their environment.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Directing Effect of Substituents: meta-Directing Groups
Directing Effect of Substituents: ortho–para-Directing Groups
Directional Terms
Directional Relays

